Drugs / ONC1-0013B
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03074032 | Jun 2014 → Apr 2017 | castration-resistant prostate carcinoma | Avionco LLC | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ONC1-0013B | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03074032 ↗ |
| Route | Oral | “ONC1-0013B per os daily” NCT03074032 ↗ |